This is especially concerning with products advertised as retatrutide, GLP-3, research peptides, or compounded versions of popular medications
This is the primary safety metric for the insulin resistance concern
Nadolsky says that for some of his patients at the highest dose of tirzepatide, the drug is sometimes "dampening that dopamine reward system down so much that now, instead of just getting away from those addictive behaviors, they don't feel like doing anything." Some of those high-dose patients start seeking out sugar, not due to cravings, he says, but because their bodies are searching for some kind of stimulation to get the reward system going again
Evidence from clinical trials and real-world data suggests these medications can be used safely in many older people, but certain precautions are essential
[2] [5] High doses of acetaminophen are known to deplete endogenous glutathione stores, particularly in the liver, which may increase the risk of toxicity